Fieldpoint Private Securities’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3K Sell
45
-20
-31% -$1.1K ﹤0.01% 1080
2022
Q1
$3K Hold
65
﹤0.01% 1426
2021
Q4
$4K Hold
65
﹤0.01% 1341
2021
Q3
$4K Hold
65
﹤0.01% 1323
2021
Q2
$4K Hold
65
﹤0.01% 1279
2021
Q1
$3K Buy
65
+60
+1,200% +$2.52K ﹤0.01% 1326
2020
Q4
$0 Buy
+5
New +$178 ﹤0.01% 1532
2017
Q4
Sell
-749
Closed -$38K 523
2017
Q3
$38K Buy
+749
New +$38.3K 0.02% 422

Other funds holding PBH

Fieldpoint Private Securities's PBH Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Prestige Consumer Healthcare (PBH) stake by 31% in Q2 2022, selling an estimated $1.1K and leaving 45 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Fieldpoint Private Securities first reported a position in PBH in Q3 2017 and has held it in 8 quarters since. The position peaked at $38K in Q3 2017. 284 funds tracked by Wall St. Rank hold PBH as of Q2 2022.

  • Fieldpoint Private Securities held 45 shares of Prestige Consumer Healthcare worth $3K as of Q2 2022.
  • Fieldpoint Private Securities sold 20 Prestige Consumer Healthcare shares in Q2 2022, an estimated $1.1K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1080 holding.
  • Fieldpoint Private Securities first reported a position in Prestige Consumer Healthcare in Q3 2017 and has held it in 8 quarters since.
  • Fieldpoint Private Securities's Prestige Consumer Healthcare position peaked at $38K in Q3 2017.
  • 284 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.